Cord Blood Registry ^Private

Cord Blood Registry (CBR) is the world's largest newborn stem cell company, founded in 1992. CBR is dedicated to advancing the clinical application of cord blood and cord tissue stem cells by partnering with institutions to establish FDA-regulated clinical trials for conditions that have no cure today. They have helped over 300 families use their cord blood stem cells for established and experimental medical treatments, more than any other family cord blood bank. CBR's goal is to expand the potential scope of newborn stem cell therapies that may be available to patients and their families. They have the longest history of accreditation with the AABB and their quality standards have been recognized through ISO 9001:2008 certification.